Posts Tagged: Cell & Tissue Engineering
Professor Paul Santerre has been elected as a Fellow of the National Academy of Inventors (NAI), the highest professional distinction awarded to academic inventors. This honour recognizes individuals whose patented innovations have made a significant and lasting impact on quality of life, economic development, and the advancement of society.
The Craig Simmons Lab at the University of Toronto investigates how biomechanical forces shape the behavior of cells, driving regeneration, repair, and disease in cardiovascular tissues. By integrating experimental and computational cell mechanics with state-of-the-art molecular biology, the lab uncovers how heart valve calcification develops, how stem cells can be guided to rebuild tissue, and how lab-on-a-chip technologies can accelerate drug testing. Their work is redefining the future of cardiovascular medicine through mechanobiology and engineering innovation.
In Professor Alison McGuigan’s lab at the University of Toronto, researchers are creating artificial tissues that mimic the complexity of the human body. These engineered tissues help scientists discover new drugs, predict how patients might respond to treatment, and even reveal who might be at higher risk for certain diseases. By combining tools from biomaterials, microfabrication, and synthetic biology, the McGuigan Lab is pioneering a new frontier in regenerative medicine and personalized health care.
AmacaThera Inc. (co-founded by Prof. Molly Shoichet), a biotechnology company focused on hydrogel-based drug delivery systems, has entered into an exclusive worldwide licensing agreement with Pacira BioSciences, Inc. for the development and commercialization of AMT-143, an investigational long-acting non-opioid anesthetic intended for post-operative pain management.
Professor Rodrigo Fernandez-Gonzalez and his team study how cells coordinate to shape and repair tissues. Using live imaging and bioengineering tools in fruit fly embryos, they uncover how cells move, communicate, and generate forces to heal wounds and form organs like the heart. Their discoveries could lead to new ways to promote healing and improve regenerative medicine.
Professor Milica Radisic has recently been featured in CBC News for her pioneering work in bioengineering and personalized medicine. With a focus on organ on a chip, these lab-grown models using a patient’s own cells to simulate organ function and tumor response. These devices offer a promising alternative to traditional drug testing methods, potentially improving the accuracy of cancer treatment predictions and reducing reliance on animal testing.
boutIQ Solutions, a Toronto-based biotech startup, is transforming cell therapy by using AI and machine learning to optimize cell culture media formulations. Their innovative approach tackles one of regenerative medicine’s toughest challenges: keeping lab-grown cells healthy, functional, and clinically ready.
Professor Milica Radisic (BME, ChemE) has been elected a fellow of the Canadian Academy of Health Sciences (CAHS), one of Canada’s three national academies. The CAHS leverages the expertise of Canada’s leading health sciences researchers to evaluate our most urgent and complex health challenges and recommend solutions. To be named a CAHS Fellow is considered one of the highest distinctions for academics in the health sciences in Canada.
Four BME core faculty members receive CIHR Project Grant funding Four core faculty members from the University of Toronto’s Institute of Biomedical Engineering (BME) have received funding from the Canadian […]
The Discovery Grant program supports researchers exploring new frontiers to address critical challenges, including environmental protection, food security, and sustainable construction in cold climates. It seeks to sustain a diverse and high-quality research ecosystem in the natural sciences and engineering at Canadian universities, foster excellence, and create an engaging environment for research training.
Showing 1 - 10 of 120 results